These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30673899)
1. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival. Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899 [TBL] [Abstract][Full Text] [Related]
2. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer. Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169 [TBL] [Abstract][Full Text] [Related]
3. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer. Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814 [TBL] [Abstract][Full Text] [Related]
4. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10. Zheng J; Ge P; Liu X; Wei J; Wu G; Li X Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883 [TBL] [Abstract][Full Text] [Related]
5. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. Ding K; Tan S; Huang X; Wang X; Li X; Fan R; Zhu Y; Lobie PE; Wang W; Wu Z J Biol Chem; 2018 Mar; 293(11):3949-3964. PubMed ID: 29367342 [TBL] [Abstract][Full Text] [Related]
6. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells. Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582 [TBL] [Abstract][Full Text] [Related]
7. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer. Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563 [TBL] [Abstract][Full Text] [Related]
8. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells. Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594 [TBL] [Abstract][Full Text] [Related]
9. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374 [TBL] [Abstract][Full Text] [Related]
10. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP. Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125 [No Abstract] [Full Text] [Related]
12. HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway. Yao S; He L; Zhang Y; Ye L; Lai Y; Huang L; Wu L; Wu G; Zhu S Biochem Biophys Res Commun; 2018 Jun; 501(3):628-635. PubMed ID: 29753747 [TBL] [Abstract][Full Text] [Related]
13. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640 [TBL] [Abstract][Full Text] [Related]
14. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895 [TBL] [Abstract][Full Text] [Related]
15. HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines. Li J; Tong G; Huang C; Luo Y; Wang S; Zhang Y; Cheng B; Zhang Z; Wu X; Liu Q; Li M; Li L; Ni B J Cell Physiol; 2020 Apr; 235(4):3579-3591. PubMed ID: 31552684 [TBL] [Abstract][Full Text] [Related]
16. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer. Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343 [TBL] [Abstract][Full Text] [Related]
17. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
18. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice. Qiu J; Li X; He Y; Sun D; Li W; Xin Y J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279 [TBL] [Abstract][Full Text] [Related]
19. Expression of sushi domain containing two reflects the malignant potential of gastric cancer. Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711 [TBL] [Abstract][Full Text] [Related]
20. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer. Uno Y; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y Ann Surg Oncol; 2019 Mar; 26(3):836-844. PubMed ID: 30617870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]